Navigation Links
Milestone Scientific Inc. Commences Trading on the OTC Pink
Date:3/14/2011

LIVINGSTON, N.J., March 14 , 2011 /PRNewswire/ -- Milestone Scientific Inc. (Pink Sheets: MLSS) which develops, manufactures, and markets computer-controlled injection systems for medical and dental markets, today announced that its common stock has commenced trading on the OTCQB(TM) electronic quotation and trading system under the ticker symbol MLSS.PK.  Stockholders are not required to take any action as a result of the addition of the Company's securities to the OTCQB(TM).

The OTCQB(TM) marketplace was created in 2010 by Pink OTC Markets Inc. as a special tier of the OTC market to better distinguish companies that are registered and reporting with U.S. regulators from non-reporting companies.  Pink OTC Markets makes Real-Time Level 2 market maker quotations for all OTCQB securities available to investors on www.otcmarkets.com.  Pink OTC Markets Inc. now operates the leading electronic interdealer quotation and trading system and facilitates trading in over 9,000 securities not listed on a U.S. stock exchange.

The Company's securities are no longer being quoted by any market maker on the OTC Bulletin Board operated by Financial Regulatory Authority, Inc. (FINRA). The OTCBB(TM) is a quotation service for FINRA market makers and not an issuer listing service or securities market.

The OTCQB(TM) and the OTCBB(TM) are competing inter-dealer quotation systems. Although the securities of some companies are still quoted on both systems, there has recently been a substantial migration of trading volume from the OTCBB(TM) to the OTCQB(TM) for technology, cost, and service reasons. The OTCQB(TM) is widely viewed as superior to the OTCBB(TM) by market makers and issuers because the OTCBB(TM) does not support electronic trading and does not offer issuer services to its quoted companies.

Milestone Scientific Inc.

Milestone Scientific, the recognized leader in advanced injection technologies, is engaged in pioneering proprietary, innovative, technological solutions for the medical and dental markets.  Central to the Company's IP platform and product development strategy is its patented CompuFlo® technology for the improved and painless delivery of local anesthetic.  Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids.  The STASingle Tooth Anesthesia System(TM), a computer-controlled local anesthesia delivery system, uses this technology to provide dentists with audible and visual signals as to in-tissue pressure.  Milestone's existing painless injection instruments are currently sold in 25 countries.  For more information on these and other innovative Milestone products, please visit the Company's web site found at www.milestonescientific.com and www.STAis4U.com.

This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. They are based upon management's reasonable belief as of the date hereof.

For additional information, please contact:

Leonard Osser, CEO, at (973) 535-2717




'/>"/>
SOURCE Milestone Scientific Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ajinomoto Co.s Capsiate Natura® Reaches New Milestone
2. Lilly Marks Major Milestone for Mirror Portfolio with Agreement by Independent Fund to License First Two Investigational Medicines
3. AndroScience Corporation Awarded a $3.8 Million, 3-Year Milestone-Driven, Cooperative Translational Research Grant from the NIH to Develop an Oral Treatment for Spinal Bulbar Muscular Atrophy (Kennedys Disease)
4. Canadian Pharmacy Intermediary SaveRxCanada.com Celebrates Milestone
5. Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration
6. Catalyst Biosciences Receives Milestone Payment from Pfizer for Progress in Lead Hemostasis Program
7. Cayenne Medical, Inc. Reaches 50,000 Implant Milestone
8. FDA Approves Pradaxa, Marking a Major Milestone to Reduce the Risk of Stroke in Patients with Non-Valvular Atrial Fibrillation
9. Stereotaxis Achieves Intellectual Property Milestone With 100th U.S. Patent
10. Health Robotics Surpasses 100 Installations Milestone and Acquires Two I.V. Room of the Future Partner Companies
11. JDRF Reaches Milestone in Artificial Pancreas Project in Partnership with UC Santa Barbara and Sansum Diabetes Research Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Research and Markets has ... Market Analysis 2016 - Forecast to 2022" report to ... report contains up to date financial data derived from varied ... major trends with potential impact on the market during the ... segmentation which comprises of sub markets, regional and country level ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
(Date:6/23/2016)... June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations ... Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... ... its strategic partnership with Connance, a healthcare industry leader providing predictive analytics ... proprietary technology combine to provide health systems, hospitals and ambulatory surgical centers ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
Breaking Medicine News(10 mins):